ANITA WOLF: Open Payments
NPI 1477156982 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 32 payments from 15 companies in 2025. Trend: 2023 $361 · 2024 $341 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $211 |
| Medtronic, Inc. | 4 | $174 |
| Aurinia Pharma U.S., Inc. | 3 | $71 |
| ABBVIE INC. | 2 | $52 |
| Amgen Inc. | 2 | $47 |
| Tandem Diabetes Care, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| UCB, Inc. | 2 | $32 |
| Corcept Therapeutics | 2 | $31 |
| Insulet Corporation | 1 | $28 |
Products named: MINIMED 780G, ZEPBOUND, LUPKYNIS, SKYRIZI, TEPEZZA, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, Bimzelx.
Industry payments across CA — which companies pay providers there.
